Description
Cladribine is a prescription injectable medication used as a chemotherapy drug to treat certain blood cancers, such as hairy cell leukemia. It works as a purine antimetabolite to interfere with cancer cell growth. Manufactured by Fresenius Kabi USA, LLC, it's administered intravenously at a strength of 1 mg/mL in single-dose vials. Approved under ANDA076571 since 2004. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Cladribine | HTML | Access the FDA dataset for Cladribine — ANDA 218425 submitted by Mylan Institutional LLC | Open resource |